SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Morphotek Inc. Receives $2.7M in Funding from the National Institute of Allergy And Infectious Diseases (NIAID) to Develop Therapeutic Antibodies Against Biowarfare Agents